Nurse Practitioner, Family · Ruston, LA
NPI
1093157927
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
707 S Vienna St
Ruston, LA, 71270
Phone (318) 224-3044
Groups this clinician bills Medicare through
Medicare paid, 2024
$169K
8,284 services
Medicare patients, 2024
365
Average age 71
Drug cost, 2024
$2.9M
4,977 prescriptions
Company payments, 2025
$3,139
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica Stewart was code 99214 (office e&m - established), 1,168 times for 329 patients. In total Jessica Stewart billed 8,284 services in 41 codes, and Medicare paid $169K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,168 | 329 | $66.21 | $77K |
| 82947 Clinical Chemistry | Office | 1,122 | 165 | $3.75 | $4,209 |
| 95251 Test - Miscellaneous | Office | 711 | 226 | $17.60 | $13K |
| 83036 Blood Count | Office | 594 | 271 | $9.48 | $5,633 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 590 | 246 | $9.33 | $5,506 |
| 99454 E&M - Miscellaneous | Office | 292 | 57 | $23.45 | $6,846 |
| 96521 Chemotherapy | Office | 209 | 11 | $64.00 | $13K |
| 96365 Intravenous Infusion, Hydration | Office | 201 | 11 | $32.77 | $6,586 |
| 96366 Intravenous Infusion, Hydration | Office | 201 | 11 | $10.83 | $2,177 |
| 82570 Clinical Chemistry | Office | 174 | 173 | $4.97 | $865 |
| 82043 Clinical Chemistry | Office | 165 | 164 | $5.53 | $913 |
| 93923 Duplex Scan - Extremity Arteries | Office | 134 | 133 | $63.70 | $8,536 |
| 99212 Office E&M - Established | Office | 95 | 72 | $31.57 | $2,999 |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 78 | 42 | $34.92 | $2,724 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 56 | 25 | $35.91 | $2,011 |
By year: 2022 $136K for 4,089 services; 2023 $149K for 5,056 services; 2024 $169K for 8,284 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 1,122 | 165 | $3.75 | $4,209 |
| 83036 Blood Count | 594 | 271 | $9.48 | $5,633 |
| 82570 Clinical Chemistry | 174 | 173 | $4.97 | $865 |
| 82043 Clinical Chemistry | 165 | 164 | $5.53 | $913 |
Medicare prescription drug claims, 2024
In 2024, the drug Jessica Stewart prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 602 prescriptions and refills. In total Jessica Stewart wrote 4,977 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 602 | 661 | 105 | $684K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 567 | 671 | 92 | $464K |
| Metformin Hcl Er Metformin Hcl | 420 | 791 | 112 | $3,625 |
| Ozempic Semaglutide | 276 | 356 | 74 | $332K |
| Jardiance Empagliflozin | 219 | 283 | 54 | $162K |
| Farxiga Dapagliflozin Propanediol | 153 | 197 | 39 | $109K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 136 | 158 | 18 | $80K |
| Novolog Insulin Aspart | 125 | 135 | 36 | $28K |
| Metformin Hcl Generic | 100 | 167 | 26 | $674 |
| Humalog Kwikpen U-200 Insulin Lispro | 95 | 111 | 19 | $203K |
| Trulicity Dulaglutide | 91 | 114 | 19 | $106K |
| Humalog Insulin Lispro | 89 | 117 | 23 | $22K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 87 | 130 | 38 | $5,605 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 80 | 108 | 21 | $60K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 79 | 130 | 22 | $53K |
Brand drugs: 2,923 claims; generic drugs: 1,281 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica Stewart $3,139 ($3,139 in general payments such as food, travel and fees) from 20 companies. The largest payer was Dexcom, Inc. with $995.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 30 | $995 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 16 | $345 |
| Novo Nordisk Inc NVO | 20 | $334 |
| Lilly USA, LLC LLY | 12 | $201 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $193 |
| Beta Bionics, Inc. BBNX | 5 | $176 |
| Insulet Corporation PODD | 7 | $160 |
| Sequel Med Tech, LLC | 5 | $109 |
| Corcept Therapeutics CORT | 4 | $109 |
| Tandem Diabetes Care, Inc. TNDM | 5 | $90.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.